Cresset Asset Management’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,440
| Closed | -$97.2K | – | 1879 |
|
|
2023
Q4 | $97.2K | Sell |
10,440
-10
| -0.1% | -$93 | ﹤0.01% | 1735 |
|
|
2023
Q3 | $68.4K | Sell |
10,450
-250
| -2% | -$1.64K | ﹤0.01% | 1692 |
|
|
2023
Q2 | $87K | Hold |
10,700
| – | – | ﹤0.01% | 1684 |
|
|
2023
Q1 | $91.7K | Hold |
10,700
| – | – | ﹤0.01% | 779 |
|
|
2022
Q4 | $99.1K | Buy |
10,700
+250
| +2% | +$2.32K | ﹤0.01% | 671 |
|
|
2022
Q3 | $108K | Hold |
10,450
| – | – | ﹤0.01% | 830 |
|
|
2022
Q2 | $105K | Hold |
10,450
| – | – | ﹤0.01% | 881 |
|
|
2022
Q1 | $129K | Hold |
10,450
| – | – | ﹤0.01% | 934 |
|
|
2021
Q4 | $181K | Sell |
10,450
-104
| -1% | -$1.8K | ﹤0.01% | 1059 |
|
|
2021
Q3 | $190K | Buy |
+10,554
| New | +$190K | ﹤0.01% | 1041 |
|